Evidence map›Paper›PMID 41852359›Full record

ArticleInternational medical case reports journal2026

Multiple Red Flags of Transthyretin Amyloid Cardiomyopathy in a Single Patient: A Case Report on Diagnostic Challenge.

Lingling Yao, Kexin Chen, Fusheng Zhang, Jun Qin

Abstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lingling Yao *Cardiac Care Unit, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Kexin Chen *Cardiac Care Unit, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Fusheng ZhangCardiac Care Unit, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.
Jun QinDepartment of Hematopathology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, infiltrative cardiomyopathy caused by misfolded transthyretin proteins forming amyloid fibers that deposit in the myocardial interstitium. It may present with multi-systems involvement. Diagnostic delay is common due to non-specific symptoms. Case Summary: We present a case of ATTR-CM with autonomic neuropathy as initial symptom, accompanied by multi-system manifestations. After being shuffled between multiple hospitals and departments, it was eventually found that his symptoms matched several "red flags" of ATTR-CM. Following the diagnostic algorithm, he underwent a 99Tcm-PYP imaging and was finally diagnosed with ATTR-CM. In our manuscript, we outline the diagnostic pathway recommended by the latest guidelines and review treatment strategies that are available and emerging. Discussion: Since early diagnosis is crucial for improving clinical outcomes for patients, we would like to highlight the pitfalls in diagnosing this disease and emphasize the need to be aware of its variable clinical presentation and red flags.

Indexed as

amyloidosisautonomic neuropathycardiomyopathymulti-organ damagetransthyretin

Identifiers

PMID41852359
PMCPMC12994531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.